9 completed, 4 unknown, 1 terminated, 1 withdrawn. 15 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 15 | Completed 9, Unknown 4, Terminated 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Meloxicam: new trials by email Literature Review of Meloxicam trials Research Report on Meloxicam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Ovulation in Obese Women Levonorgestrel 1.5 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram - Pregnancy Prevention | Phase 2 | Completed | InnovaGyn, Inc. | 4 | 2023-12-10 | 2026-06-30 |
| Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery Meloxicam Injection 30mg, Meloxicam Injection 60mg, Nacl 0.9% - Pain, Post-operative | Phase 2 | Unknown | Beijing Tide Pharmaceutical Co., Ltd | 108 | 2023-07-01 | 2023-07-18 |
| Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo - Pregnancy Prevention | Phase 2 | Completed | InnovaGyn, Inc. | 19 | 2022-06-28 | 2026-09-09 |
| Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials Celecoxib, Naproxen, Meloxicam - Axial Spondyloarthritis | Phase 2 | Terminated | The University of Texas Health Science Center, Houston | 42 | 2020-06-25 | 2025-08-13 |
| Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis Bawei Shenqi Pill, Bawei Shenqi Pill placebo, Meloxicam - Ankylosing Spondylitis | Phase 2 / Phase 3 | Unknown | Shanghai University of Traditional Chinese Medicine | 80 | 2017-10-01 | 2020-08-14 |
| Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis Pain Meloxicam Test Capsules, Meloxicam Tablets - Osteoarthritis | Phase 2 | Withdrawn | Iroko Pharmaceuticals, LLC | 2015-05-01 | 2015-07-10 | |
| Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea Meloxicam, Diclofenac Potassium, Placebo Oral - Dysmenorrhea | Phase 2 / Phase 3 | Completed | Laboratorios Andromaco S.A. | 68 | 2014-06-27 | 2019-05-03 |
| A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma Meloxicam, Filgrastim - Multiple Myeloma, Non-Hodgkin's Lymphoma | Phase 2 | Completed | Sherif S. Farag | 38 | 2014-03-11 | 2021-02-21 |
| Meloxicam vs Placebo for Mobilization GCSF, meloxicam, Placebo - Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Phase 2 | Completed | Massachusetts General Hospital | 31 | 2013-10-01 | 2020-05-18 |
| Discontinuing NSAIDs in Veterans With Knee Osteoarthritis Meloxicam 15 mg po QD, Cognitive Behavioral Therapy - Knee Osteoarthritis | Phase 2 | Completed | VA Office of Research and Development | 490 | 2013-09-02 | 2023-07-27 |
| Study of a COX-2 Inhibitor for Prevention of Ovulation Meloxicam - Rupture; Graafian Follicle | Phase 2 | Unknown | Instituto Chileno de Medicina Reproductiva | 56 | 2011-01-01 | 2011-05-03 |
| Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis TNF alpha, NSAIDs and sulfasalazine - Ankylosing Spondylitis | Phase 2 | Unknown | Chung Shan Medical University | 300 | 2009-11-01 | 2015-05-28 |
| Single Dose Study of N1539 in the Treatment of Pain Secondary to Dental Impaction Surgery N1539, placebo, Motrin - Dental Pain | Phase 2 | Completed | Alkermes, Inc. | 230 | 2009-07-01 | 2011-12-02 |
| Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third Molar Meloxicam 7.5 mg, Meloxicam 3.75 mg, Meloxicam 1.875 mg - Pain | Phase 2 | Completed | Boehringer Ingelheim | 381 | 1998-04-01 | 2014-07-08 |
| Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea Meloxicam 7.5 mg, Meloxicam 15 mg, Mefenamic acid 500 mg - Dysmenorrhea | Phase 2 | Completed | Boehringer Ingelheim | 337 | 1998-01-01 | 2018-08-31 |
Dysmenorrhea (2) · Lymphoma, Non-Hodgkin (2) · Multiple Myeloma (2) · Spondylitis, Ankylosing (2) · Axial Spondyloarthritis (1) · Hodgkin Disease (1) · Osteoarthritis (1) · Osteoarthritis, Knee (1) · Pain (1) · Pain, Postoperative (1) · Rupture (1) · Spondylitis (1) · Toothache (1)
Boehringer Ingelheim (2) · InnovaGyn, Inc. (2) · Alkermes, Inc. (1) · Beijing Tide Pharmaceutical Co., Ltd (1) · Chung Shan Medical University (1) · Instituto Chileno de Medicina Reproductiva (1) · Iroko Pharmaceuticals, LLC (1) · Laboratorios Andromaco S.A. (1) · Massachusetts General Hospital (1) · Shanghai University of Traditional Chinese Medicine (1) · Sherif S. Farag (1) · The University of Texas Health Science Center, Houston (1) · VA Office of Research and Development (1)
United States (7) · Chile (2) · China (2) · Taiwan (1)
Andrea Lukes, MD (1) · Bimalangshu Dey, MD (1) · David F. Archer, MD (1) · Mark C Hwang, MD (1) · Sherif Farag, M.D., Ph.D. (1) · Steven Christensen, DDS (1) · Wei C- C, M.D. (1) · William L. McPheat, PhD (1)
PMID 23114735, PMID 12441312, PMID 15541405, PMID 16009156, PMID 16798842, PMID 16855077, PMID 16980507, PMID 18929686, PMID 19933235, PMID 23040128, PMID 24835831, PMID 24909636, PMID 25259677, PMID 26025453, PMID 26830816, PMID 29329493, PMID 30737315, PMID 32702101, PMID 34510361, PMID 40676732
KL2TR003168 (1), R43HD104508 (1), R43HD107861 (1)